Tinidazole for M. genitalium infection in men
Part of Infections clinical trials.
This study tests the antibiotic tinidazole for treating Mycoplasma genitalium infection in people with urethritis (inflammation of the urine tube). It aims to see how well the drug clears the infection and improves sexual health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with nongonococcal urethritis (NGU).
- You tested positive for Mycoplasma genitalium in the last 7 days.
- You were assigned male at birth.
- You are able to return for a test-of-cure visit 21 days after treatment.
- You are not allergic to tinidazole.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a specific lab test (the “gyrA assay”) can detect gonorrhea in people who do not have symptoms. It may help clinicians find gonorrhea more quickly and with the right treatment when symptoms aren’t present.
This trial compares two medicines, metronidazole and secnidazole, to find the best way to treat trichomonas, a common sexually transmitted infection. If you have trichomonas and haven't been treated yet, you may be able to join.
This trial tests a new antibiotic, omadacycline, for men with a persistent urethral infection caused by mycoplasma genitalium that hasn't cleared with standard treatments. If you've completed the usual two-step antibiotic course and still have symptoms, this study might offer another option.
This trial tests a combination of three medicines (doxycycline, pentoxifylline, and nitazoxanide) to treat gonorrhea and chlamydia in men. The goal is to see if this combination works better than standard treatment.
This study tests two ways to prevent STIs in men who have sex with men in Kenya: taking antibiotics only when you have symptoms, or taking a single antibiotic pill (doxycycline) shortly after sex. It aims to find which approach works better for keeping you healthy.
This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.
Hear when a new Mycoplasma Genitalium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.